Dexpramipexole: Lou Gehrig's Disease Drug Fails In Trial
In the 943-patient late-stage trial, dexpramipexole failed to slow decline of physical or respiratory function or improve
dexpramipexole lou gehrig disease drug fail trial patient late stage trial dexpramipexole fail slow decline physical respiratory function improve